Neuroprotective effects of NEP1-40 and fasudil on Nogo-A expression in neonatal rats with hypoxic-ischemic brain damage

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 2987-2995

  Zhu, W W ^a   Ma, X L ^a   Guo, A L ^a   Zhao, H Y ^a   Luo, H H ^a  

^a JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Fasudil; Hypoxic ischemic brain damage; NEP1 40; Nogo A

Indexed keywords

FASUDIL; MESSENGER RNA; NEP 1 40; NEUROPROTECTIVE AGENT; PROTEIN NOGO A; UNCLASSIFIED DRUG; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; DRUG DERIVATIVE; MYELIN PROTEIN; NEP1 40 PROTEIN, HUMAN; NEP1-40 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEIN NOGO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; BRAIN; CAROTID ARTERY; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIGATION; METABOLISM; METHODOLOGY; NERVE CELL; PATHOLOGY; WISTAR RAT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CAROTID ARTERIES; FEMALE; GENE EXPRESSION; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS, INTRAPERITONEAL; LIGATION; MALE; MYELIN PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 84861803860     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.November.29.9     Document Type: Article

References (24)

1. Bertrand J, Winton MJ, Rodriguez-Hernandez N, Campenot RB, et al. (2005). Application of rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J. Neurosci. 25: 1113-1121.
2. Cao Y, Shumsky JS, Sabol MA, Kushner RA, et al. (2008). Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil. Neural Repair 22: 262-278.
3. Fournier AE, Takizawa BT and Strittmatter SM (2003). Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23: 1416-1423.
4. Gillani RL, Tsai SY, Wallace DG, O'Brien TE, et al. (2010). Cognitive recovery in the aged rat after stroke and anti-Nogo-A immunotherapy. Behav. Brain Res. 208: 415-424.
5. Goldshmit Y, Galea MP, Wise G, Bartlett PF, et al. (2004). Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J. Neurosci. 24: 10064-10073.
6. GrandPre T, Li S and Strittmatter SM (2002). Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417: 547-551.
7. Guo AL, Zhu WW, Wang L and Pan F (2008). Effect of NEP1-40 in inhibiting neurite outgrowth on neonatal rats with hypoxic ischemic brain damage. Chin. J. Child Health Care 16: 679-668.
8. Hossain MA (2008). Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int. J. Dev. Neurosci. 26: 93-101.
9. Kim SS, Lee KH, Sung DK, Shim JW, et al. (2008). Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. J. Korean Med. Sci. 23: 484-491.
10. Kottis V, Thibault P, Mikol D, Xiao ZC, et al. (2002). Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82: 1566-1569.
11. Kubo T and Yamashita T (2007). Rho-ROCK inhibitors for the treatment of CNS injury. Recent Patents CNS Drug Discov. 2: 173-179.
12. McKerracher L, David S, Jackson DL, Kottis V, et al. (1994). Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13: 805-811.
13. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, et al. (1994). A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13: 757-767.
14. Oertle T, van der Haar ME, Bandtlow CE, Robeva A, et al. (2003). Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 23: 5393-5406.
15. Perlman JM (2006). Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin. Ther. 28: 1353-1365.
16. Prinjha R, Moore SE, Vinson M, Blake S, et al. (2000). Inhibitor of neurite outgrowth in humans. Nature 403: 383-384.
17. Rice JE III, Vannucci RC and Brierley JB (1981). The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9: 131-141.
18. Savio T and Schwab ME (1990). Lesioned corticospinal tract axons regenerate in myelin-free rat spinal cord. Proc. Natl. Acad. Sci. U. S. A. 87: 4130-4133.
19. Schnaar RL and Lopez PH (2009). Myelin-associated glycoprotein and its axonal receptors. J. Neurosci. Res. 87: 3267-3276.
20. Vicari RM, Chaitman B, Keefe D, Smith WB, et al. (2005). Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J. Am. Coll. Cardiol. 46: 1803-1811.
21. Walmsley AR and Mir AK (2007). Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr. Pharm. Des. 13: 2470-2484.
22. Wang H, Yao Y, Jiang X, Chen D, et al. (2006). Expression of Nogo-A and NgR in the developing rat brain after hypoxia-ischemia. Brain Res. 1114: 212-220.
23. Wong ST, Henley JR, Kanning KC, Huang KH, et al. (2002). A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5: 1302-1308.
24. Yesilirmak DC, Kumral A, Tugyan K, Cilaker S, et al. (2008). Effects of activated protein C on neonatal hypoxic ischemic brain injury. Brain Res. 1210: 56-62.